相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unmet Needs in Hispanic/Latino Patients with Type 2 Diabetes Mellitus
Kenneth Cusi et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings
Elizabeth M. Brunt et al.
HEPATOLOGY (2011)
Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
Elizabeth K. Speliotes et al.
PLOS GENETICS (2011)
Pioglitazone in the treatment of NASH: the role of adiponectin
A. Gastaldelli et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
Kenneth Cusi
CURRENT DIABETES REPORTS (2010)
Effects of PNPLA3 on Liver Fat and Metabolic Profile in Hispanic Children and Adolescents
Michael I. Goran et al.
DIABETES (2010)
The Natural History of Non-Alcoholic Fatty Liver Disease
Stephen Caldwell et al.
DIGESTIVE DISEASES (2010)
Clinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease
Brent A. Nettschwander-Tetri et al.
HEPATOLOGY (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent
S. Romeo et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Noreen Hossain et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
Kenneth Cusi
CLINICS IN LIVER DISEASE (2009)
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
A. Kotronen et al.
DIABETOLOGIA (2009)
Ethnic Differences in Hepatic Steatosis: An Insulin Resistance Paradox?
Richard Guerrero et al.
HEPATOLOGY (2009)
Importance of Changes in Adipose Tissue Insulin Resistance to Histological Response During Thiazolidinedione Treatment of Patients with Nonalcoholic Steatohepatitis
Amalia Gastaldelli et al.
HEPATOLOGY (2009)
Influence of ethnicity on histological differences in non-alcoholic fatty liver disease
Smruti R. Mohanty et al.
JOURNAL OF HEPATOLOGY (2009)
A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity
Silvia Sookoian et al.
JOURNAL OF LIPID RESEARCH (2009)
Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: The impact of triglycerides
Eric R. Kallwitz et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Metabolic correlates of nonalcoholic fatty liver in women and men
Gloria Lena Vega et al.
HEPATOLOGY (2007)
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
Amalia Gastaldelli et al.
GASTROENTEROLOGY (2007)
Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women - The Women's Health Initiative Observational Study
Yiqing Song et al.
DIABETES CARE (2007)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease
SR Weston et al.
HEPATOLOGY (2005)
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
LS Szczepaniak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Ethnic differences in the prevalence of cryptogenic cirrhosis
JD Browning et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes
S Kashyap et al.
DIABETES (2003)
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: A physiological analysis
E Ferrannini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle
K Cusi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
